257 related articles for article (PubMed ID: 21741958)
1. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.
Ly VT; Brock B
Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochrome P450 inhibitors on peroxidase activity.
Martinkova M; Kubickova B; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant.
Miller MG; Beyer J; Hall GL; deGraffenried LA; Adams PE
Toxicol Appl Pharmacol; 1993 Sep; 122(1):108-16. PubMed ID: 8378925
[TBL] [Abstract][Full Text] [Related]
4. Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine.
Wang Y; Wang S; Liu Y; Yan L; Dou G; Gao Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):292-300. PubMed ID: 16949890
[TBL] [Abstract][Full Text] [Related]
5. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
7. The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.
Carcillo JA; Korzekwa KR; Jones GS; Parise RA; Gillespie DG; Whalen MJ; Kochanek PM; Branch RA; Kost CK
Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):57-68. PubMed ID: 9920346
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
Tang J; Amin Usmani K; Hodgson E; Rose RL
Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
11. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
[TBL] [Abstract][Full Text] [Related]
12. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole.
Moorthy B; Parker KM; Smith CV; Bend JR; Welty SE
J Pharmacol Exp Ther; 2000 Feb; 292(2):553-60. PubMed ID: 10640292
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
[TBL] [Abstract][Full Text] [Related]
15. Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator?
Linder CD; Renaud NA; Hutzler JM
Drug Metab Dispos; 2009 Jan; 37(1):10-3. PubMed ID: 18936109
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity of precocene I in rats. Role of metabolic activation in vivo.
Ravindranath V; Boyd MR; Jerina DM
Biochem Pharmacol; 1987 Feb; 36(4):441-6. PubMed ID: 3827936
[TBL] [Abstract][Full Text] [Related]
17. In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.
Liu ZY; Chen DM; Huang LL; Tao YF; Yao M; Yuan ZH
Toxicology; 2011 Jan; 279(1-3):155-66. PubMed ID: 20955753
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
Baranczewski P; Edlund PO; Postlind H
J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM
Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
